Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Capital Employed (2016 - 2025)

Cumberland Pharmaceuticals' Return on Capital Employed history spans 15 years, with the latest figure at 0.08% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 6.0% year-over-year to 0.08%; the TTM value through Dec 2025 reached 0.08%, up 6.0%, while the annual FY2025 figure was 0.03%, N/A changed from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.08% at Cumberland Pharmaceuticals, down from 0.08% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.07% in Q2 2021 and bottomed at 0.14% in Q4 2024.
  • The 5-year median for Return on Capital Employed is 0.09% (2024), against an average of 0.09%.
  • The largest annual shift saw Return on Capital Employed rose 7bps in 2021 before it fell -6bps in 2022.
  • A 5-year view of Return on Capital Employed shows it stood at 0.12% in 2021, then increased by 22bps to 0.09% in 2022, then dropped by -2bps to 0.09% in 2023, then tumbled by -56bps to 0.14% in 2024, then skyrocketed by 44bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Return on Capital Employed are 0.08% (Q4 2025), 0.08% (Q3 2025), and 0.07% (Q2 2025).